drug · small molecule
patient view →trilaciclib
Marketedupdated 2mo agoby Pharmacosmos AS🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for small cell lung carcinoma and 10 investigational indications.
targets
Cyclin-dependent kinase 6Cyclin-dependent kinase 4
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that